NCT05382559 2026-04-14A Study of ASP3082 in Adults With Advanced Solid TumorsAstellas Pharma IncPhase 1 Recruiting681 enrolled
NCT07020221 2026-04-03A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsVerastem, Inc.Phase 1/2 Recruiting295 enrolled
NCT04205812 2026-03-31POD1UM-304Incyte CorporationPhase 3 Active not recruiting583 enrolled 22 charts
NCT06561685 2026-03-27A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Recruiting340 enrolled
NCT06917079 2026-03-23BBO-11818 in Adult Subjects With KRAS Mutant CancerTheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Phase 1 Recruiting387 enrolled